Cargando…

Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects

Introduction: The COVID-19 pandemic is a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe illness and controlling the pandemic. This study aimed to examine how immunosuppressed patients with inflammatory bowel disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vollenberg, Richard, Lorentzen, Eva Ulla, Kühn, Joachim, Nowacki, Tobias Max, Meier, Jörn Arne, Trebicka, Jonel, Tepasse, Phil-Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536352/ https://www.ncbi.nlm.nih.gov/pubmed/37766088 http://dx.doi.org/10.3390/vaccines11091411

Ejemplares similares

Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study
por: Vollenberg, Richard, et al.
Publicado: (2022)

Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
por: Vollenberg, Richard, et al.
Publicado: (2022)

Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study
por: Rennebaum, Florian, et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis
por: Bokemeyer, Arne, et al.
Publicado: (2023)

Familial Mediterranean fever and COVID-19. An ancient disease in a pandemic of the new millennium: is it an epiphenomenon of infection?
por: Sensoy, Timur S, et al.
Publicado: (2021)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
por: Dugas, Martin, et al.
Publicado: (2021)

The Renin–Angiotensin System in COVID-19: Can Long COVID Be Predicted?
por: König, Simone, et al.
Publicado: (2023)

The Dysregulation of the Renin–Angiotensin System in COVID-19 Studied by Serum Proteomics: Angiotensinogen Increases with Disease Severity
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

High Angiotensin-Converting Enzyme and Low Carboxypeptidase N Serum Activity Correlate with Disease Severity in COVID-19 Patients
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

Reduced Vitamin A RBP Levels in Hospitalized COVID-19 Patients
por: Tepasse, Phil-Robin, et al.
Publicado: (2022)

Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
por: Vollenberg, Richard, et al.
Publicado: (2021)

Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients
por: Vollenberg, Richard, et al.
Publicado: (2022)

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
por: Tepasse, Phil‐Robin, et al.
Publicado: (2020)

Prone Position in Mechanically Ventilated COVID-19 Patients: A Multicenter Study
por: Vollenberg, Richard, et al.
Publicado: (2021)

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression
por: Tyc, Olaf, et al.
Publicado: (2023)

Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever
por: Boeckel, Göran Ramin, et al.
Publicado: (2022)

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
por: Higgins, Peter D R, et al.
Publicado: (2020)

Anpassung der Therapie von gastroenterologischen und hepatologischen Erkrankungen bei COVID-19-Infektion
por: Trebicka, Jonel
Publicado: (2021)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
por: Dugas, Martin, et al.
Publicado: (2021)

Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020
por: Wiegele, Patricia Nicole, et al.
Publicado: (2021)

Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
por: Varghese, Julian, et al.
Publicado: (2021)

Target-Specific Fluorescence-Mediated Tomography for Non-Invasive and Dynamic Assessment of Early Neutrophil Infiltration in Murine Experimental Colitis
por: Nowacki, Tobias M., et al.
Publicado: (2019)

Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
por: Jörrißen, Philipp, et al.
Publicado: (2021)

Assessment of impact of a novel infectious bursal disease (IBD) vaccination programme in breeders on IBD humoral antibody levels through the laying period
por: Parker, Daniel, et al.
Publicado: (2014)

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
por: Le, Peter N., et al.
Publicado: (2015)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Pre-primary and Primary Prophylaxis of Variceal Hemorrhage
por: Sauerbruch, Tilman, et al.
Publicado: (2013)

Acute-on-chronic liver failure: a global disease
por: Schulz, Martin, et al.
Publicado: (2022)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges
por: Kimmann, Markus, et al.
Publicado: (2023)

Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series
por: Boeckel, Göran Ramin, et al.
Publicado: (2022)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience
por: Evers, Georg, et al.
Publicado: (2022)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l6nsuo5vrb7sjs22b70fsjt9j7